Clinical Trials Directory

Trials / Completed

CompletedNCT04066842

Vitamin D in Systemic Sclerosis Patients With Periodontitis

Evaluation Of Vitamin D In Systemic Sclerosis Patients With Periodontitis: A Possible Role In Cardiovascular Disease Risk Progression?

Status
Completed
Phase
Study type
Observational
Enrollment
168 (actual)
Sponsor
University of Messina · Academic / Other
Sex
All
Age
20 Years – 75 Years
Healthy volunteers
Accepted

Summary

Vitamin D has been considered to possess anti-inflammatory and antimicrobial activity which may be a link for the known interaction of Systemic Sclerosis (SSc) and coronary heart disease (CHD). This study investigated the association between serum vitamin D levels and SSc and periodontitis in patients with SSc, CP and with CHD. Furthermore, the objective was to determine if periodontitis and CHD had an impact on serum vitamin D levels.

Detailed description

Using a cross-sectional design, a total of 42 patients with SSc, 43 patients with CHD, 41 patients with both SSc and CP, and 42 healthy patients were enrolled in the present study.

Conditions

Interventions

TypeNameDescription
OTHERObservationEvaluation of Vitamin D levels and correlation of Vitamin D levels level with periodontal and cardiovascular disease

Timeline

Start date
2015-11-01
Primary completion
2019-05-15
Completion
2019-05-30
First posted
2019-08-26
Last updated
2019-08-26

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04066842. Inclusion in this directory is not an endorsement.